1. The enteropathy of prostaglandin deficiency

   • David H. Adler
   • John A. Phillips III
   • John A. Oates

   International Forum 1 16 January 2009 Pages: 1 - 7

2. Long-term use of nonsteroidal anti-inflammatory drugs normalizes the kinetics of gastric epithelial cells in patients with Helicobacter pylori infection via attenuation of gastric mucosal inflammation

   • Tetsuya Tanigawa
   • Toshio Watanabe
   • Tetsuo Arakawa

   International Forum 1 16 January 2009 Pages: 8 - 17

3. The role of microRNAs in gastrointestinal cancers

   • Yoshimasa Saito
   • Hidekazu Suzuki
   • Toshifumi Hibi

   International Forum 1 16 January 2009 Pages: 18 - 22

4. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy

   • Ingvar Bjarnason
   • Ken Takeuchi

   International Forum 1 16 January 2009 Pages: 23 - 29

5. Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells

   • Tatsushi Omatsu
   • Yuji Naito
   • Toshikazu Yoshikawa

   International Forum 1 16 January 2009 Pages: 30 - 34

6. Mast cells are involved in the pathogenesis of indomethacin-induced rat enteritis

   • Tetsuya Okayama
   • Norimasa Yoshida
   • Toshikazu Yoshikawa

   International Forum 1 16 January 2009 Pages: 35 - 39

7. Helicobacter pylori and NSAID-induced gastric ulcer in a Japanese population

   • Kazunari Murakami
   • Tadayoshi Okimoto
   • Toshio Fujioka

   International Forum 1 16 January 2009 Pages: 40 - 43

8. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy

   • Barry Schlansky
   • Joo Ha Hwang

   International Forum 1 16 January 2009 Pages: 44 - 52

9. Cyclooxygenase-2 inhibitors in patients with high gastrointestinal risk: are we there yet?

   • Vincent Wai-Sun Wong
   • Francis Ka-Leung Chan

   International Forum 1 16 January 2009 Pages: 53 - 56

10. Nonsteroidal anti-inflammatory drug-induced small-bowel lesions identified by double-balloon endoscopy: endoscopic features of the lesions and endoscopic treatments for diaphragm disease

    • Yoshikazu Hayashi
    • Hironori Yamamoto
    • Kentaro Sugano

    International Forum 1 16 January 2009 Pages: 57 - 63

11. Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy

    • Laurence Maiden

    International Forum 1 16 January 2009 Pages: 64 - 71

12. NSAIDs and colorectal cancer prevention

    • Takeo Iwama

    International Forum 1 16 January 2009 Pages: 72 - 76

13. Chemoprevention of colorectal cancer in Japan: a brief introduction to current clinical trials

    • Hideki Ishikawa
    • Tomiyo Nakamura
    • Toshiyuki Sakai

    International Forum 1 16 January 2009 Pages: 77 - 81

14. Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection

    • Kazuhiko Koike

    International Forum 2 16 January 2009 Pages: 82 - 88

15. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

    • Etsuko Hashimoto
    • Satoru Yatsuji
    • Keiko Shiratori

    International Forum 2 16 January 2009 Pages: 89 - 95

16. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology

    • Stephen Caldwell
    • Sang H. Park

    International Forum 2 16 January 2009 Pages: 96 - 101

17. Epidemiology of hepatocellular carcinoma in Japan

    • Takeji Umemura
    • Tetsuya Ichijo
    • Kendo Kiyosawa

    International Forum 2 16 January 2009 Pages: 102 - 107

18. Early HCC: diagnosis and molecular markers

    • Michiie Sakamoto

    International Forum 2 16 January 2009 Pages: 108 - 111

19. Multistep human hepatocarcinogenesis: correlation of imaging with pathology

    • Masatoshi Kudo

    International Forum 2 16 January 2009 Pages: 112 - 118

20. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines

    • Norihiro Kokudo
    • Masatoshi Makuuchi

    International Forum 2 16 January 2009 Pages: 119 - 121

21. Image-guided percutaneous ablation therapies for hepatocellular carcinoma

    • Shuichiro Shiina

    International Forum 2 16 January 2009 Pages: 122 - 131

22. Resection and liver transplantation for HCC

    • Jacques Belghiti

    International Forum 2 16 January 2009 Pages: 132 - 135

23. Molecular targeted therapy for hepatocellular carcinoma

    • Melanie Thomas

    International Forum 2 16 January 2009 Pages: 136 - 141

24. Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation

    • Ryosuke Tateishi
    • Shuichiro Shiina
    • Masao Omata

    International Forum 2 16 January 2009 Pages: 142 - 146